/u/montaukwhaler's posts in /r/nsclc
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study)
3 upvotes
Mark as read: Add to a list
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
2 upvotes
Mark as read: Add to a list
Cycloalliin, an Organosulfur Compound in Garlic, Inhibits EMT and Invasion of the A549 Non-Small Cell Lung Cancer Cell Line
2 upvotes
Mark as read: Add to a list
Repurposing Antiviral Drugs as Potential Anti-EGFR Agents in NSCLC: A Structure-Based Screening and Molecular Dynamics Analysis
2 upvotes
Mark as read: Add to a list
Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC
2 upvotes
Mark as read: Add to a list
Analysis of surgical complexity and short-term prognostic indicators in NSCLC patients: neoadjuvant targeted therapy versus neoadjuvant chemoimmunotherapy
2 upvotes
Mark as read: Add to a list
Homologous recombination deficiency status predicts response to immunotherapy-based treatment in non-small cell lung cancer patients
2 upvotes
Mark as read: Add to a list
SIRT1 silencing promotes EMT and Crizotinib resistance by regulating autophagy through AMPK/mTOR/S6K signaling pathway in EML4-ALK L1196M and EML4-ALK G1202R mutant non-small cell lung cancer cells
2 upvotes
Mark as read: Add to a list
WNT5B promotes the malignant phenotype of non-small cell lung cancer via the FZD3–DVL3–RAC1–PCP–JNK pathway
2 upvotes
Mark as read: Add to a list